Compare Global Payments Inc (GPN) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global Payments Inc vs BIO-TECHNE Corp — how do they compare? Global Payments Inc trades at $86.06 (market cap $22.79B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: Global Payments Inc is far larger — about 2× BIO-TECHNE Corp's market cap, and Global Payments Inc pays the higher dividend (1.16%). Which is the better fit depends on your goals.
| GPN | TECH | |
|---|---|---|
Market Cap | $22.79B | $11.24B |
Sector | Industrials | Health |
52-Week High | $90.01 | $72.29 |
52-Week Low | $62.47 | $43.31 |
Enterprise Value | $40.94B | $11.32B |
Dividend Yield | 1.16% | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Global Payments (GPN) trades at $86.12, down 1.79% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability margins and positive cash flow, though net income margin and ROE are negative. Recent news highlights Q2 2026 earnings exceeding expectations, driven by Genius platform growth, despite revenue guidance adjustments.
Outlook remains supported by analyst consensus with a $96.67 price target, but risks include margin pressure from rising costs and competitive fintech threats. The stock offers upside potential if execution continues, but investors should monitor debt levels and macroeconomic impacts on payment volumes.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Global Payments Inc
Global Payments is a leading provider of payment processing and software solutions and focuses on serving small and midsize merchants. The company operates in 30 countries and generates about one fourth of its revenue from outside North America, primarily in Europe and Asia. In 2019, Global Payments merged with Total System Services in an all-stock deal that gave Total System Services shareholders 48% of the combined company's shares.
Read more on GPN →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
